Victory Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMRX
Victory Capital Management's AMRX Position: Q3 2026 in Review
Victory Capital Management reduced its Amneal Pharmaceuticals (AMRX) stake by 23% in Q3 2026, selling an estimated $2.21M and leaving 399,353 shares worth $8.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1206.
Victory Capital Management first reported a position in AMRX in Q3 2019 and has held it in 29 quarters since. The position peaked at $12M in Q1 2021. 332 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.
- Victory Capital Management held 399,353 shares of Amneal Pharmaceuticals worth $8.04M as of Q3 2026.
- Victory Capital Management sold 122,535 Amneal Pharmaceuticals shares in Q3 2026, an estimated $2.21M.
- Amneal Pharmaceuticals made up ﹤0.01% of Victory Capital Management's portfolio in Q3 2026, its #1206 holding.
- Victory Capital Management first reported a position in Amneal Pharmaceuticals in Q3 2019 and has held it in 29 quarters since.
- Victory Capital Management's Amneal Pharmaceuticals position peaked at $12M in Q1 2021.
- 332 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.
Based on Victory Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.